These fifteen DEGs, including AKT2, CCL2, HSP90AA1, PDE5A, PTGS1, BCHE, SERPINB5, CA2, SRC, DGKA, HIF1A, PTGS2, ABCA1, DPYD, and AKR1C3 were potential target of wogonin to enhance gemcitabine sensitivity in pancreatic cancer. The gene discussed is ABCA1; the disease is familial pancreatic carcinoma.